Viking Therapeutics, Inc. (VKTX)

NASDAQ

$38,54

$+9,63

(+31,98%)

Regular Market

Viking Therapeutics, Inc. (VKTX) Live Price Chart

Last updated: ⁦2026-09-22 14:27:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Viking Therapeutics, Inc. (VKTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $38,54, with a market capitalisation of $3,38B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $24,52 to $45,61. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3,38B
Open	$37,00
Day's High	$99,41
Day's Low	$0,88
Previous Close	$30,11
Volume	20,88M
Average Volume	2,29M
P/E Ratio	--
52-Week High	$45,61
52-Week Low	$24,52
Dividend Yield	--
Earnings Date	--

Viking Therapeutics, Inc. (VKTX) Stock Price Today

Viking Therapeutics, Inc. (VKTX) is currently trading at $38,54 as of 2026-09-22 14:10:59, up 27,98% ($8,43) from the previous close of $30,11

During today's regular trading session, VKTX has traded between $0,88 and $99,41, with a trading volume of 20,88M shares. The current price is near the lower end of today's range.

Viking Therapeutics, Inc. (VKTX) 7-Day Stock Price Change

Over the past seven days, Viking Therapeutics, Inc. (VKTX) moved from $31,98 to $38,54, representing a gain of 20,50% ($6,56).

The stock traded between $28,40 and $45,61 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 2,82 million shares, up versus the previous seven-day period, indicating higher trading activity.

VKTX 52-Week Price Position

Position in Range: 66,5%

52W Low$24,52

52W High$45,61

VKTX is currently trading at $38,54, placing it 66,5% of the way from its 52-week low of $24,52 to its 52-week high of $45,61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Viking Therapeutics, Inc. (VKTX)?

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Viking Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	65
Exchange	NASDAQ
Company Website	https://www.vikingtherapeutics.com

How to Buy Viking Therapeutics, Inc. (VKTX) Stock on MEXC

Eligible investors can buy real shares of Viking Therapeutics, Inc. (VKTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VKTX and Place Your Order

Open the RealStocks trading page and search for VKTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Viking Therapeutics, Inc. (VKTX) stock price today?

Viking Therapeutics, Inc. (VKTX) is currently trading at $ 38,54, up 27,98% ($8,43) from the previous close of $ 30,11. Intraday prices update in real time during regular trading hours.

2.Is VKTX stock going up or down today?

As of 2026-09-22 14:10:59, VKTX is trading at $ 38,54, up 27,98% ($8,43) from its previous close of $ 30,11. The stock has traded between $ 0,88 and $ 99,41 during today’s regular session. Past price movements do not guarantee future results.

3.What is VKTX pre-market price?

As of 2026-09-22 14:10:59, VKTX is trading at $ 38,73 in pre-market trading, up 28,64% ($8,62) from the previous close of $ 30,11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VKTX after-hours price?

As of 2026-09-22 14:10:59, VKTX is trading at $ 30,60 in after-hours trading, up 1,64% ($0,49) from the regular-session close of $ 30,11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VKTX stock trading now?

VKTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VKTX sit relative to its 52-week high and low?

Over the past 52 weeks, VKTX has traded between a low of $ 24,52 and a high of $ 45,61. At $ 38,54, the stock is positioned 66,5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Viking Therapeutics, Inc. in?

Viking Therapeutics, Inc. (VKTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Viking Therapeutics, Inc.'s market capitalisation and where is it listed?

Viking Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 3,38B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VKTX valued in terms of P/E ratio and EPS?

VKTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4,58. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Viking Therapeutics, Inc. pay a dividend?

Viking Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.